Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan H Cole

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Immunotoxicology|December 4, 2014
Characterization of the draining lymph node response in the mouse drug allergy model: A model for drug hypersensitivity reactionsXu Zhu, Susan H Cole, Thomas T Kawabata, et al.
The Journal of Investigative Dermatology|September 21, 2007
Essential role of CCR6 in directing activated T cells to the skin during contact hypersensitivityTimothy J Paradis, Susan H Cole, Robin T Nelson, et al.
Journal of Immunotoxicology|November 12, 2010
Human lymphocyte activation assay: an in vitro method for predictive immunotoxicity testingMark Collinge, Susan H Cole, Patricia A Schneider, et al.
Cancer Immunology, Immunotherapy : CII|April 12, 2011
The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu miceRonald P Gladue, Timothy Paradis, Susan H Cole, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2006
The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic miceRonald P Gladue, Susan H Cole, Marsha L Roach, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Immunotoxicology|December 4, 2014
Characterization of the draining lymph node response in the mouse drug allergy model: A model for drug hypersensitivity reactionsXu Zhu, Susan H Cole, Thomas T Kawabata, et al.
The Journal of Investigative Dermatology|September 21, 2007
Essential role of CCR6 in directing activated T cells to the skin during contact hypersensitivityTimothy J Paradis, Susan H Cole, Robin T Nelson, et al.
Journal of Immunotoxicology|November 12, 2010
Human lymphocyte activation assay: an in vitro method for predictive immunotoxicity testingMark Collinge, Susan H Cole, Patricia A Schneider, et al.
Cancer Immunology, Immunotherapy : CII|April 12, 2011
The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu miceRonald P Gladue, Timothy Paradis, Susan H Cole, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2006
The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic miceRonald P Gladue, Susan H Cole, Marsha L Roach, et al.
Pageof 1